ORIGINAL RESEARCH article
Front. Neurol.
Sec. Stroke
Volume 16 - 2025 | doi: 10.3389/fneur.2025.1606563
This article is part of the Research TopicFrom bench to bedside: Inflammation in Neurovascular Disorders and StrokeView all 11 articles
Immunoinflammatory Biomarkers as Predictors of Hemorrhagic Transformation in Acute Ischemic Stroke Patients After Endovascular Thrombectomy
Provisionally accepted- Department of Stroke Center, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Hemorrhagic transformation (HT) and symptomatic intracranial hemorrhage (sICH) are common complications of endovascular thrombectomy (EVT) in acute ischemic stroke (AIS) patients. The role of peripheral immune inflammation in HT after EVT is unclear. This study aimed to evaluate the relationship between immune inflammatory factor levels and HT and sICH occurrence, and to develop predictive models.Methods: We included 81 AIS patients who underwent EVT. Peripheral blood samples were collected immediately post-EVT to measure immunoinflammatory markers. Least absolute shrinkage and selection operator (LASSO) regression was used to select variables, and backward stepwise multivariable logistic regression identified independent predictors and predictive models for HT and sICH. The models’ discrimination was assessed using the area under the receiver operating characteristic curve (AUC), and calibration was evaluated using the Hosmer–Lemeshow test. Logistic regression models were used to evaluate the impact of HT or sICH on 90-day functional outcomes and mortality.Results: The HT rate was 39.51% (32/81), and the sICH rate was 17.07% (14/81). Multivariate analysis revealed that HT after EVT was significantly associated with collateral score (OR 0.27 [95% CI 0.13-0.52], p<0.001), arteriosclerosis etiology (OR 0.11 [95% CI 0.02-0.46], p=0.006), puncture to recanalization time (OR 3.72 [95% CI 1.07-14.59], p=0.04), and levels of IL-6 (OR 7.33 [95% CI 2.1-31.07], p=0.003; AUC 0.696 (95% CI 0.593−0.799)). sICH was independently related to direct aspiration (DA) techniques (OR 0.07 [95% CI 0.09-0.35], p=0.004) and neutrophil-to-albumin ratio (NAR) values (OR 5.69 [95% CI 1.16-37.24], p=0.044; 0.676 (95% CI 0.550−0.803)). Both predictive models for HT (AUC 0.898 (95% CI 0.831−0.965)) and sICH (AUC 0.925 (0.853−0.997)) exhibited good discrimination and calibration.Conclusion: IL-6 and NAR are potential biomarkers for predicting HT and sICH in AIS patients after EVT. This study developed simple and effective predictive models for HT and sICH based on immunoinflammatory factors. Future research should explore the spatiotemporal effects of immune inflammation on prognosis in AIS patients undergoing EVT.
Keywords: Hemorrhagic transformation (HT), Acute ischemic stroke (AIS, endovascular thrombectomy (EVT), sICH = symptomatic intracerebral hemorrhage, IL-6, neutrophil-to-albumin ratio, immunoinflammatory biomarkers
Received: 05 Apr 2025; Accepted: 27 May 2025.
Copyright: © 2025 Bao, Wang and He. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Shuang He, Department of Stroke Center, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.